Trials / Completed
CompletedNCT01529931
Long Term Efficiency of the Hair2Go Device
Follow Up Study: The Effect Of Hair2Go Maintenance Treatments on Long Term Hair Removal
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Syneron Medical · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The current study is a follow up study designed to gather information about the effect of the number of Hair2Go maintenance treatments on hair clearance 1 year after the last basic Hair2Go treatment. This study includes taking photos and documenting endpoints but does not include treatments.
Detailed description
The Hair2Go device is intended for short-term and long-term removal of unwanted hair adjunctive to shaving. The device uses a technology called Elōs, which is a combination of electrical field at radio frequencies (RF) and intense optical energy, that are simultaneously applied to the tissue and were found to have synergistic effects. Thus, lower levels of both energies are used to facilitate the treatment for individuals of all skin types and hair colors. This study is a multicenter study. Subjects that completed the basic treatments of previous Hair2Go studies (OHR-2, OHR-3, or OHR-5-Face) will be offered the option to enroll in this study that will not include treatments. The individual data collected in the OHR-2 (and its extensions, i.e. OHR2-P and OHR2-1Y), OHR-3, and OHR-5-Face studies will be used for the analysis together with data gathered in this study. Photographs of the previously treated areas will be taken 3, 6, 9, and 12 months after the last basic treatment if they were not already taken as part of the OHR-2, one of its extensions (i.e. OHR2-P and OHR2-1Y), or OHR-5-Face.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hair2Go | Hair2Go treatment once a month for 6 months |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-10-01
- Completion
- 2012-11-01
- First posted
- 2012-02-09
- Last updated
- 2019-01-18
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01529931. Inclusion in this directory is not an endorsement.